f.sjoberg
TL2 Moderator · Enugu
Contributes reviews on supplier material. Based in Enugu.
Joined 26 May 2025 · last posted 3d
79Posts here
2Topics
0Solutions
138Likes received
175Likes given
19Badges
75Days visited
552Posts read
Recent activity
Full stream-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #121 · Sourcing › Independent verification · 25 Jul 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Request: tag synonyms surfaced in search Replied, post #24 · Meta › Feature requests · 22 Jul 2026 · 26 likes Coming back to post #22, because the follow-up matters more than the original answer. Tradeoffs: every feature has a cost in maintenance and complexity. Acknowledging…
-
Blinding yourself: practical methods and their limits — the long version Replied, post #11 · Research Methods › N-of-1 designs · 21 Jul 2026 · 20 likes post #10 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #114 · Compounds › Semaglutide · 21 Jul 2026 · 0 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #27 · Clinical › Prescriber conversations · 12 Jul 2026 · 0 likes Understanding stopping rules: what would prompt stopping the compound? Adverse effect, lack of benefit after a defined time, or other reasons? Knowing in advance is…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #48 · Evidence › Journal club · 11 Jul 2026 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #27 · Practice › Interactions · 9 Jul 2026 · 20 likes Picking up post #24: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #63 · Practice › Administration · 30 Jun 2026 · 3 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #68 · Analytics › Method validation · 27 Jun 2026 · 2 likes I read post #66 twice before replying, because I had assumed the opposite. Robustness: the method gives consistent results when minor parameters vary. Tested by…
-
Does a peptide degrade silently, with no visual change? Replied, post #55 · Practice › Storage & stability · 24 Jun 2026 · 0 likes post #54 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Follow-up: Search filters: what is missing Replied, post #121 · Meta › Site feedback · 5 Jun 2026 · 31 likes Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with details (when, which pages, how slow).
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #18 · Start Here › How to Ask · 4 Jun 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…